Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
LII enters its October 22 earnings report under unusual pressure: a Goldman Sachs downgrade landed the same morning short interest hit a 30-day high, with index-rebalance flows adding a further mechanical overhang the stock has not previously faced.
The Goldman move is the sharpest analyst action in months. Joe Ritchie cut his rating to Neutral from Buy and dropped his price target to $390 from $547, a 29% target reduction. That puts his new target only 11% above the current $350.13 close. Oppenheimer and RBC both lowered their targets on the same day, to $548 and $406 respectively, though both firms kept their existing ratings. The broader Street remains cautious: the consensus is a Hold with 13 analysts there against just 3 Buys, and the mean price target of $455 implies roughly 30% upside from current levels. That gap between target and price looks wide until you note the stock was trading near $460 before July's earnings collapse.
Short interest has rebuilt sharply since mid-September. Shorts on LII now account for 7.6% of the free float, up 20% over the past week and 54% over the past month. The stock was running at roughly 5% short interest as recently as late September. Despite the speed of that accumulation, the borrow market is not especially tight. Availability remains ample at 421%, meaning there are more than four shares available to lend for every one already borrowed, and the cost to borrow is just 0.53%, well within normal territory. The ORTEX short score edged up to 54.9 this week, a moderate reading that reflects the direction of travel without signalling an extreme. Options positioning is broadly neutral: the put/call ratio of 1.18 is just below its 20-day average of 1.22, with the z-score near flat. There is no unusual hedging activity ahead of the print.
The most structurally important overhang for LII may be the index rebalance rather than the earnings. ORTEX puts the probability at 99% that LII is removed from the MSCI USA, MSCI World, MSCI North America, and MSCI Kokusai indices at the November 2026 quarterly review, with potential forced selling of up to $656 million in the MSCI World alone, equivalent to 3.6 days of normal trading volume. At the same time, ORTEX forecasts a 99% probability of addition to the MSCI USA Small and MSCI World Small indices, which would generate offsetting buying of around $437 million and $219 million respectively. The critical price level is $433.75: LII is currently 23.9% below that line, the threshold at which the MSCI large-cap inclusion rule flips. The rank date is October 19, just five days away, and if confirmed, the announcement is expected November 11 with the trade date November 30.
The earnings history sharpens the risk framing. LII's last report on July 29 produced a one-day decline of 23.3% and the stock shed a further 17.9% over the following five days. That move brought the stock from near the $460 level down to its current trading range. Before that, the prior quarter saw a one-day gain of 1.6% followed by a five-day loss of 21.6%. The reaction function has been consistently large and predominantly negative over recent prints.
The activist register adds one more layer. John Norris III holds a 13D position in LII, having raised his stake from 9.2% to 9.8% of the class as last disclosed in June 2025. A 13D signals active intent rather than passive holding. The Norris Family Limited Partnership is the third-largest institutional holder with 7.4% of shares. As with all 13D/G disclosures, stakes reflect the position at last filing; a holder can move below 5% without a further filing.
The next eight days are dense with information. Earnings land on October 22. The MSCI rank date is October 19, after which ORTEX's rebalance forecast either crystallises or dissolves. What makes this setup unusual is that the two events arrive so close together, with the index flow decision potentially already baked before the Street hears from management.
See the live data behind this article on ORTEX.
Open LII on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
